The Human Papillomavirus Vaccine (HPV): Another Case for Adopting the Precautionary Principle

“According to a paper in the Annals of Medicine, Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?: “At present there are no significant data showing that either Gardasil or Cervarix (GlaxoSmithKline) can prevent any type of cervical cancer since the testing period employed was too short to evaluate long-term benefits of HPV vaccination.”

In the US, France, Spain and Denmark, more than 250 court cases are being mounted over HPV vaccinations. Damages have been won in the US and France.

However, the UK medicines watchdog, the Medicines and Healthcare Products Regulatory Agency (MHRA) and Public Health England say that the HPV jab is the most effective way to protect against cervical cancer, which kills 900 UK women each year and the American government’s CDC (Centers for Disease Control and Prevention) recommends the Gardasil vaccine, made by Merck Pharmaceuticals, for all females between 9 and 26 years to protect against HPV.”
Read the whole article here!



Go back to: Vaccination – A Controversial Medical Science Topic

Comments are closed.